Covenant has emerged from stealth with the introduction of Anthem, a heavy-payload and long-range weapon system developed to close the West's precision strike gap. The company announced the move alongside a new Texas factory, facilities in Germany and Israel, and more than $250 million in funding across three rounds. Covenant also reported approximately $150 million in orders from existing customers in the United States, Europe, and other allied markets.
Strategic Need for Affordable Precision Strike
Modern conflicts are consuming long-range precision strike missiles faster than the defense industrial base can replace them, according to Covenant. The company designed Anthem to be produced in the thousands and deliver heavy payload and long range at a fraction of legacy system costs. Founder and CEO Michael Kaufman said that credible deterrence requires holding adversary targets at risk without allowing stockpiles to run thin.
Flight Testing and Validation
Since Anthem's first flight in August 2025, Covenant has conducted more than 200 flights, including multiple tests with the U.S. Army at home and abroad. These tests have stress-tested every element of the weapon system's design. Former Deputy Secretary of Defense Kathleen Hicks noted that Anthem aligns with the Replicator Initiative's principles of moving fast to scale affordable autonomous capabilities.
An End-to-End Deep Strike System
Anthem is built as an end-to-end deep strike solution that is transported, stored, launched, and reloaded with minimal strain and expense for customers. Covenant has also developed its own mission planning and command-and-control software for coordinated mass launch operations. Most parts are commercial off-the-shelf, with long-term strategic agreements securing other key components through local allied supply chains.
Manufacturing Footprint Across Three Countries
U.S. production will take place in a new 105,000 square foot facility in Dallas, Texas, which opened with the announcement and will begin serial production in the first quarter of 2027. The site is expected to ramp toward 5,000 units per year. Covenant also operates a 110,000 square foot facility in Saxony, Germany, and a 32,000 square foot facility in Northern Israel.
Booked Orders and Military Partnerships
Covenant has booked approximately $150 million in orders including qualification, research and development, and multiple production contracts. The company is under an Other Transaction Agreement with the U.S. Army for an accelerated test and qualification program. It is also working with the U.S. Navy's Rapid Capabilities Office to adapt the ground-launched Anthem into a Maritime Anthem variant, a project valued at roughly $70 million.
Investor Confidence and Industrial Scaling
The funding rounds were led by Andreessen Horowitz, Founders Fund, Lux, 8VC, Aleph, and Lightspeed. Andreessen Horowitz General Partner David Ulevitch said Covenant has technical depth and urgency, and the company has proven its system in flight. Covenant is also scaling its engineering, manufacturing, and operations teams at the Texas site to support production goals.
Covenant's emergence from stealth marks a significant expansion of allied long-range strike production capacity at a time of growing defense demands. With facilities on three continents, proven flight testing, and early military contracts, the company is positioning Anthem as a scalable and affordable alternative to legacy precision weapons. Its ability to execute on production timelines will now be the central measure of success as allied forces seek affordable massed firepower.